Aditxt, Inc. (ADTX) Financials
ADTX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 8.2 million | 12.4 million |
2023-06-30 | 7.3 million | 11.2 million |
2023-03-31 | 10.7 million | 5.5 million |
2022-12-31 | 10.7 million | 5.5 million |
ADTX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -8.0 million | 153992 |
2023-06-30 | -3.3 million | 163228 |
2023-03-31 | -6.8 million | 614247 |
2022-12-31 | -6.8 million | 614247 |
ADTX Net Income
No data available :(
ADTX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 1.7 million | - | 2.3 million |
2023-06-30 | 95953 | - | 2.5 million |
2023-03-31 | 2.8 million | - | 2.8 million |
2022-12-31 | - | - | 3.0 million |
ADTX Shares Outstanding
ADTX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 9356 | 898724 | 7.2 million | 44186 |
2023-06-30 | 2 | 484835 | 3.7 million | 113759 |
2023-03-31 | 88823 | 3.1 million | 3.7 million | 937472 |
2022-12-31 | 88823 | 3.1 million | 4.6 million | - |
ADTX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 124486 | 106922 |
2023-06-30 | 220978 | 185738 |
2023-03-31 | 185596 | 170166 |
2022-12-31 | 185596 | 170166 |
ADTX
Price: $2.30
52 week price:
Earnings Per Share: -12.00 USD
P/E Ratio: -0.32
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 201000
Market Capitalization: 5.0 million